This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ali, M. Articles by Coates, P. E. Search for Related Content PubMed PubMed Citation Articles by Ali, M. Articles by Coates, P. E.

Stroke, Vol 11, 9-13, Copyright © 1980 by American Heart Association

ARTICLES

Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin

M Ali, JW McDonald, JJ Thiessen and PE Coates

Compressed and enteric-coated acetylsalicylate (ASA) tablets have been compared in normal healthy subjects. Plasma ASA and salicylate (SA) were measured by high pressure liquid chromatography (HPLC). Platelet cyclooxygenase activity in vitro was studied by a radiometric technique. Following ingestion of 650 mg of ASA in the form of compressed tablets, cyclooxygenase activity was inhibited 95% within 45 min. Enzyme activity was observed to increase within 8 h and reached 10% of control level by 24 h. The pattern suggests that only circulating platelets are affected by ASA ingestion. Following the administration of 650 mg of ASA as enteric-coated tablets comparable inhibition of cyclooxygenase activity was observed, although the effect was delayed, reflecting the delayed appearance of ASA in the plasma. Return to control levels followed a pattern similar to that observed with the compressed tablet.

This article has been cited by other articles:

				L. Cullen, L. Kelly, S. O. Connor, and D. J. Fitzgerald Selective Cyclooxygenase-2 Inhibition by Nimesulide in Man J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 578 - 582. [Abstract] [Full Text]

				R. G. Hart and M. J.G. Harrison Aspirin Wars : The Optimal Dose of Aspirin to Prevent Stroke Stroke, April 1, 1996; 27(4): 585 - 587. [Full Text]

				G. P. Clagett Antithrombotic Drugs and Vascular Surgery Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1990; 3(2): 79 - 102. [PDF]